<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Pharmaids Pharmaceuticals has filed an annual disclosure with BSE regarding its classification as a 'Large Corporate' under SEBI circulars dated August 10, 2021 and May 22, 2024. The company confirmed that as of March 31, 2025, it does not meet the criteria to be classified as a Large Corporate. This means the company is exempt from the additional borrowing and debt security requirements that apply to large corporates. The disclosure was signed by Prasanna Subramanya Bhat, Company Secretary & Compliance Officer, on April 9, 2025.
This is a routine regulatory compliance filing with no material impact on the stock or shareholders. It simply confirms the company's smaller size relative to SEBI's large corporate thresholds and has no bearing on business operations or financials.